Literature DB >> 2946901

The Fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors.

J K Kirklin, E H Blackstone, J W Kirklin, A D Pacifico, L M Bargeron.   

Abstract

One hundred two patients, aged 0.7 to 38 years, with a wide variety of cardiac malformations underwent the Fontan operation (1975 to April, 1985). Several different techniques were used. All but 17 had previously undergone one or more palliative operations. Follow-up information was obtained in all patients. Overall actuarial survival rate, with time zero being the time of the operation, was 63% at 6 years with no deaths after that in patients followed as long as out to 9.4 years; that for patients with tricuspid atresia was 81%. The hazard function (instantaneous risk) for death was highest immediately after operation and merged after about 6 months with a constant hazard extending as long as the patients were followed. Elevated post-repair right atrial pressure was correlated (p = 0.002) with the probability of death in the early phase, with the risk rising rapidly with pressures above 14 mm Hg. Hypertrophy of the ventricular main chamber was a risk factor for death in both the early (p = 0.007) and late (p = 0.008) phases of hazard, which explained in part the lesser risk of the Fontan operation in patients with tricuspid atresia. Younger age, but not older age, was a risk factor for early postoperative death, but this risk was neutralized by recent date of operation. Thus currently there is not a predicted increased risk associated with younger age at operation. In general, the Fontan operation should be done at a young age (2 to 4 years) to avoid increasing ventricular hypertrophy, but older age per se is not a contraindication to the operation.

Entities:  

Mesh:

Year:  1986        PMID: 2946901

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  22 in total

1.  Effects of arteriovenous shunt on ventricular function in dog.

Authors:  T Omoto; R Aeba; T Katogi; T Ito; S Kawada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-03

2.  Recent modifications of the fontan procedure for complex congenital heart disease.

Authors:  G J Reul; I D Gregoric
Journal:  Tex Heart Inst J       Date:  1992

Review 3.  Hearts with one ventricle: current concepts and management.

Authors:  I D Sullivan; J F Taylor
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

4.  Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation.

Authors:  G H Tatum; G Sigfússon; J A Ettedgui; J L Myers; S E Cyran; H S Weber; S A Webber
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

5.  Site of coronary sinus drainage does not significantly affect coronary flow reserve in patients long term after Fontan operation.

Authors:  A Eicken; W Sebening; T Genz; H Kaemmerer; R Lange; R Busch; J Hess
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

6.  Surgical preconditioning and completion of total cavopulmonary connection by interventional cardiac catheterisation: a new concept.

Authors:  G Hausdorf; M Schneider; W Konertz
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

7.  Pulmonary artery banding before the Damus-Kaye-Stansel procedure.

Authors:  Yun Hee Chang; Woong-Han Kim; Jae Young Lee; Soo-Jin Kim; Cheul Lee; Seong Wook Hwang; Si Chan Sung
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

8.  A reconsideration of risk factors for the Fontan operation.

Authors:  J L Myers; J A Waldhausen; H S Weber; J D Arenas; S E Cyran; M M Gleason; B G Baylen
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

9.  Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure.

Authors:  Renee Margossian; Lynn A Sleeper; Gail D Pearson; Piers C Barker; Luc Mertens; Michael D Quartermain; Jason T Su; Girish Shirali; Shan Chen; Steven D Colan
Journal:  J Am Soc Echocardiogr       Date:  2016-09-10       Impact factor: 5.251

10.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.